URECHOLINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Urecholine, and when can generic versions of Urecholine launch?
Urecholine is a drug marketed by Odyssey Pharms and is included in five NDAs.
The generic ingredient in URECHOLINE is bethanechol chloride. There are eight drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the bethanechol chloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Urecholine
A generic version of URECHOLINE was approved as bethanechol chloride by UPSHER SMITH LABS on June 1st, 2005.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for URECHOLINE?
- What are the global sales for URECHOLINE?
- What is Average Wholesale Price for URECHOLINE?
Summary for URECHOLINE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 5 |
| Raw Ingredient (Bulk) Api Vendors: | 101 |
| Clinical Trials: | 1 |
| Patent Applications: | 1,356 |
| DailyMed Link: | URECHOLINE at DailyMed |
Recent Clinical Trials for URECHOLINE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Augusta University | Phase 1 |
US Patents and Regulatory Information for URECHOLINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Odyssey Pharms | URECHOLINE | bethanechol chloride | INJECTABLE;INJECTION | 006536-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Odyssey Pharms | URECHOLINE | bethanechol chloride | TABLET;ORAL | 006536-004 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Odyssey Pharms | URECHOLINE | bethanechol chloride | TABLET;ORAL | 088440-001 | May 29, 1984 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
